The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...

UK had highest relative increase of five countries in study, with 20-fold rise in proportion of women over 25 using it ...

It has long been assumed that psychostimulants help those with ADHD by acting on the brain’s attention circuitry. However, ...

The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...

The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

PHILADELPHIA (WPVI) -- School will be back in session in the coming weeks, and parents and doctors are sounding the alarm over the ADHD medication shortages. It comes as kids are getting ready to head ...

Mass General Brigham researchers scrutinized this concern with the first-ever study comparing substance use disorder rates in patients with ADHD who were prescribed stimulant medications during ...

Seoul National University Hospital researchers have linked childhood attention-deficit/hyperactivity disorder and ...

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects someone’s attention, hyperactivity, impulsivity, and more. 1 This happens because of executive functioning ...

An analysis of U.S. Medicaid data found that 26.7% of autistic adults without intellectual disability had an ADHD diagnosis. This was the case for 40.2% of autistic adults with intellectual disability ...